R&D Systems代理3829-AN-050 Recombinant Human Angiopoietin-like 3 Protein, CF (50 UG)

2025-06-27

货号:3829-AN-050

品牌:R&D Systems

规格:50ug

目录价:¥4630.00

市场价格:¥3704.00

会员价格:¥3704.00

  • 到货时间:3~4周

    金山科研平台,产品价格货期咨询微信:jinshanbio Source:Spodoptera frugiperda, Sf 21 (baculovirus)-derived, Ser17-Glu460, with a C-terminal 10-His tag Accession #:Q9Y5C1 N-terminal Sequence Analysis:Ser17 Structure:Oligomer Purity:>90%, by SDS-PAGE under reducing conditions and visualized by silver stain. Endotoxin Level: Predicted Molecular Mass:53.2 kDa SDS-PAGE:54-59 kDa, reducing conditions Activity:Measured by its ability to inhibit lipoprotein lipase activity. Yoshida, K. et al. (2002) J. Lipid Res. 43:1770.The IC50 value under conditions in which lipoprotein lipase is present at 5 units/mL, and p-nitrophenyl butyrate concentration is 1 mM in 0.1M sodium phosphate, 0.15 M NaCl, 0.5% Triton® X-100, pH 7.2, is approximately 3.5-15 µg/mL. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS, NaCl and CHAPS.See Certificate of Analysis for details. Molecule Information: Angiopoietin-like Protein 3/ANGPTL3 Aliases: AGNPT5; Ang-5; Angiopoietin-5; ANGPTL3 Entrez Gene IDs: 27329 (Human); 30924 (Mouse) Background: Angiopoietin-like 3 Angiopoietin-like 3 (ANGPTL3) is a liver secreted glycoprotein that is structurally related to the angiopoietins, although it does not bind Tie-1 or Tie-2. Full length ANGPTL3 circulates in the plasma as do its proteolytically cleaved coiled coil and fibrinogen-like domains. ANGPTL3 promotes an increase in circulating triglyceride levels by directly inhibiting lipoprotein lipase. ANGPTL3 expression is dysregulated in some strains of obese and diabetic mice.

    © 金山科研平台是专业的授权总代理区域代理经销平台。
    © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
    © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
    © 本文地址:https://www.16ao.com/thread-134878.htm
    © R&D Systems代理3829-AN-050 Recombinant Human Angiopoietin-like 3 Protein, CF (50 UG),产品报价联系微信jinshanbio
  • 产品询价需求提交
    产品询价请加微信:jinshanbio
    返回